Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis

Inclusion Criteria

• •eligibility criteria:
• •1. voluntarily sign the ICF and comply with all the visits and research-related procedures required by the protocol;
• •2. Both men and women were required to be ≥ 18 and ≤ 80 years old at the time of signing the informed consent;
• •3. the duration of PN diagnosed by a dermatologist at the time of screening was ≥ 3 months;
• •4. In the range of 1-10, WI-NRS≥7 in the past 24 h at screening; WI-NRS in the week before the baseline visit The average weekly score was ≥ 7 points.